Alzheimer's drug lecanemab hailed as momentous breakthrough

Posted on AllSides November 30th, 2022
From The Center
Healthcare, Alzheimer's
Getty Images

The first drug to slow the destruction of the brain in Alzheimer's has been heralded as momentous.

The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible.

Yet the medicine, lecanemab, has only a small effect and its impact on people's daily lives is debated.

And the drug works in the early stages of the disease, so most would miss out without a revolution in spotting it.

Lecanemab attacks the sticky gunge -...

Read full story

BBC News

AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
111520/86501
See full bias rating for BBC News
Learn about media bias
https://www.bbc.com/news/health-63749586

More News about Healthcare from the Left, Center and Right

From the Left

From the Center

From the Right